Cardiokine Inc entered the industry of Commercial Biotechnical Research in 2012 and has grown to employ 1 to 4 people, generating an annual revenue of $1.000.000 to $2.499.999. The NAICS classifies this business under the code 541711, which describes it as a Commercial Biotechnical Research. For further clarification, the SIC classifies this business under the code 8731 and described it as a Commercial Biotechnical Research. The business provides service to the B2B market.
To acquire more information, please contact Manuel Worcel by calling (215) 399-1200 during business hours. You can also write to the business’ Headquarters at 30 South 15th St # 1500, Philadelphia, Pennsylvania PA 19102. You can also visit the company’s website at . View this business’ social media profiles on Twitter or on Facebbok .
Company: | Cardiokine Inc |
Representative: | Manuel Worcel |
Place of Business: | 30 South 15th St # 1500, Philadelphia, PA 19102 |
Contact Number: | (215) 399-1200 |
Type of Service: | Commercial Biotechnical Research |
SIC Number: | 8731 |
NAICS Number: | 541711 |
Locality: | Headquarters |
Market Type: | B2B (Business to Business) |
Began: | 2012 |
Income/Year: | $1.000.000 to $2.499.999 |
Laborers: | 1 to 4 |
Share This Company: |
Cardiokine Inc is a company operating from Philadelphia, Pennsylvania providing professional Commercial Biotechnical Research and relevant B2B variables. It was founded in 2012 and registered with the SIC code 8731 as Commercial Biotechnical Research, and with the NAICS code 541711 as Commercial Biotechnical Research.
With a current employee count of 1 to 4, Cardiokine Inc has gone to report making $1.000.000 to $2.499.999 per annum on its journey towards growth. This company invites you to contact its representative Manuel Worcel at (215) 399-1200 for related queries, or to locate its Headquarters using the coordinates 39.952453,-75.165413.
The Headquarters can also be found at the street address 30 South 15th St # 1500 in Philadelphia, Pennsylvania 19102 and can be engaged online through the company website at , the company Twitter , and Facebook page .